Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	79.95	39.01	31.64	21.25	21.83
Revenue Growth (YoY)	104.94%	23.29%	48.90%	-2.66%	55879.49%
Cost of Revenue	37.21	15.6	10.58	6.93	2.83
Gross Profit	42.74	23.41	21.06	14.32	19.01
Selling, General & Admin	35.82	22.75	18.93	18.58	14.27
Research & Development	7.77	3.26	3.32	4	6.24
Total Operating Expenses	43.58	26.01	22.25	22.58	20.5
Operating Income	-0.84	-2.6	-1.19	-8.26	-1.5
Total Non-Operating Income (Expense)	-3.71	-1.21	0.5	-0.76	-0.46
Pretax Income	-4.56	-3.81	-0.69	-9.02	-1.96
Provision for Income Taxes	0.04	0.02	0.25	-	-
Net Income	-4.6	-3.82	-0.94	-9.02	-1.96
Net Income to Common	-4.6	-3.82	-0.94	-9.02	-1.96
Shares Outstanding (Basic)	27	26	26	25	25
Shares Outstanding (Diluted)	27	26	26	25	25
Shares Change (YoY)	3.91%	0.97%	1.99%	-0.24%	19.98%
EPS (Basic)	-0.17	-0.15	-0.04	-0.36	-0.08
EPS (Diluted)	-0.17	-0.15	-0.04	-0.36	-0.08
Shares Outstanding	27.05	26.71	25.69	25.35	24.63
Free Cash Flow	10.19	0.94	6.82	4.78	-4.73
Free Cash Flow Growth	980.70%	-86.16%	42.48%	-	-
Free Cash Flow Per Share	0.38	0.04	0.27	0.19	-0.19
Gross Margin	53.46%	60.01%	66.56%	67.38%	87.05%
Operating Margin	-1.06%	-6.66%	-3.77%	-38.87%	-6.85%
Profit Margin	-5.75%	-9.80%	-2.96%	-42.45%	-8.95%
FCF Margin	12.75%	2.42%	21.54%	22.51%	-21.67%
EBITDA	3.2	-1.45	-0.29	-6.49	-1.03
EBITDA Margin	4.00%	-3.72%	-0.92%	-30.52%	-4.73%
EBIT	-0.84	-2.6	-1.19	-8.26	-1.5
EBIT Margin	-1.06%	-6.66%	-3.77%	-38.87%	-6.85%
Effective Tax Rate	-0.94%	-0.39%	-35.85%	0.00%	0.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q